Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
Molecular Cancer Therapeutics|March 16, 2005
Abrogation of fibroblast activation protein enzymatic activity attenuates tumor growthJonathan D Cheng, Matthildi Valianou, Adrian A Canutescu, et al.
Annals of Surgical Oncology|December 21, 2006
Resection of isolated pelvic recurrences after colorectal surgery: long-term results and predictors of improved clinical outcomeLeonard R Henry, Elin Sigurdson, Eric A Ross, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 30, 2005
Concomitant boost radiation plus concurrent cisplatin for advanced head and neck carcinomas: radiation therapy oncology group phase II trial 99-14K Kian Ang, Jonathan Harris, Adam S Garden, et al.
Journal of Leukocyte Biology|February 9, 2007
Dipeptidyl peptidase 8/9-like activity in human leukocytesMarie-Berthe Maes, Véronique Dubois, Inger Brandt, et al.
International Journal of Radiation Oncology, Biology, Physics|July 22, 2008
Long-term results of concomitant boost radiation plus concurrent cisplatin for advanced head and neck carcinomas: a phase II trial of the radiation therapy oncology group (RTOG 99-14)Adam S Garden, Jonathan Harris, Andy Trotti, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Selective Inhibitors of Fibroblast Activation Protein (FAP) with a (4-Quinolinoyl)-glycyl-2-cyanopyrrolidine ScaffoldKoen Jansen, Leen Heirbaut, Jonathan D Cheng, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 30, 2012
Identification of inhibitory scFv antibodies targeting fibroblast activation protein utilizing phage display functional screensJiping Zhang, Matthildi Valianou, Heidi Simmons, et al.
Practical Radiation Oncology|March 29, 2014
Women at increased risk for cardiac toxicity following chemoradiation therapy for esophageal carcinomaLauren M Tait, Joshua E Meyer, Erin McSpadden, et al.
Pageof 5